Navigation Links
Anti-smoking TV ads should use anger, Dartmouth-Cornell study suggests
Date:4/29/2014

Anti-smoking television advertisements that appeal to viewers' emotions are more persuasive when they use anger rather than sadness, a Dartmouth-Cornell study suggests.

The study appears in the Journal of Health Communication. A PDF is available on request.

Previous studies have shown emotional expression is a crucial part of persuasion, and that audience members' perceptions of emotions affect their attitudes and behaviors. Previous research also has shown anti-smoking TV ads that convey negative emotions such as anger and sadness are more effective than non-emotional approaches.

In the new study, researchers from Dartmouth College's Geisel School of Medicine and Cornell University examined how viewers process those negative emotions. They produced anti-smoking TV ads in which an actor delivered anti-smoking messages to 115 college students with either anger or sadness by using different vocal tones and facial expressions. To measure the role of emotions in the ads, the researchers manipulated the actor's expressed emotions while keeping the story the same.

Results showed the anger-framed ad was more effective because it increased the perceived dominance of the speaker, which increased anti-smoking attitudes and predicted strong intentions not to smoke. The findings also showed participants who watched the anger-framed message didn't find the actor likable or empathetic, but those factors were not associated with intention to quit smoking.


'/>"/>

Contact: John Cramer
John.Cramer@Dartmouth.edu
603-646-9130
Dartmouth College
Source:Eurekalert

Page: 1

Related medicine news :

1. Small neural focus groups predict anti-smoking ad success
2. Anti-Smoking Ads Have Increased Quit Attempts: CDC
3. Anti-Smoking Progress Stalls Among U.S. Adults: Report
4. Genes May Influence Effectiveness of Anti-Smoking Policies
5. Anti-smoking ads with strong arguments, not flashy editing, trigger part of brain involving behavior change
6. Online comments can undermine anti-smoking PSAs
7. Canada should play a role in addressing the global cancer epidemic
8. New standards for treating traumatic shoulder injuries to improve patient care
9. Should oxygen be used for patients with chronic heart failure?
10. Men Can Still Ask for PSA Test, and Some Should, Doctors Say
11. Canada should significantly increase its funding of randomized clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... May 26, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... is focusing on the Peace Agreements being discussed by President Donald Trump and the ... race to try to speed up peace talks in the continuous battle between Israel ...
(Date:5/26/2017)... ... May 26, 2017 , ... Dr. Alex Rabinovich, a highly-skilled oral ... new, informational blog post on insurance options. If a Bay Area patient has to ... save time and money. Visiting an in-network provider for a second opinion can ensure ...
(Date:5/26/2017)... Centennial, Colorado (PRWEB) , ... May 26, 2017 ... ... Exchange will be this year’s recipient of proceeds from its 14th Annual Clays ... Club, 46700 E. County Road 30, Bennett, Colorado. , As part of ...
(Date:5/26/2017)... ... May 26, 2017 , ... Water damage to the flooring of several ... had left education officials with a number of critical issues to address before students ... to be accomplished with little or no disruption to class schedules. Second, the project ...
(Date:5/24/2017)... York, New York (PRWEB) , ... May 24, 2017 , ... ... general vascular surgery in New York City. He is known for his ... broad specialization in vascular surgery, Dr. Benvenisty holds sub-specialty training in treating renovascular disease ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)... May 17, 2017  Bayer announced today that the ... be presented at the 53 rd Annual Meeting ... place June 2-6 in Chicago . ... span prostate, colorectal, liver and thyroid cancers, as well ... Phase II CHRONOS-1 trial of copanlisib in patients with ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
(Date:5/11/2017)...  Thornhill Research Inc. ( Toronto, Ontario, ... USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract by the U.S. ... (CCC) ( Ottawa, Ontario, Canada ) ... anesthesia to patients requiring emergency medical procedures in ... Corps have been a longtime partner with Thornhill ...
Breaking Medicine Technology: